(Q34972066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335784%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

review article

1 reference

title

Treatment of chronic hepatitis C in Asia: when East meets West (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335784%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335784%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Wan-Long Chuang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335784%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335784%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335784%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335784%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335784%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

336-345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335784%20AND%20SRC:MED&resulttype=core&format=json

National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.05789.X

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.05789.X

Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.05789.X

Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.05789.X

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.05789.X

Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.05789.X